Thomas Emanuel Bergh

Deputy Board Member, Alder Therapeutics AB

Uddens Gård10 active roles

Thomas Emanuel Bergh holds 10 active roles in Swedish companies registered in Bolagsverket, including Deputy Board Member at Alder Therapeutics AB since 2026 and Board of Directors at ACE Health AB since 2024. 6 earlier roles have ended, the most recent in 2025.

Overview

Active roles

directorships & management

Past roles

historical positions

Dissolved companies

Career timeline

2026 – now
Deputy Board Member, Alder Therapeutics AB
2024 – now
Board of Directors, ACE Health AB
2023 – now
Deputy Board Member, Välfärdspartner AB
2022 – now
Board of Directors, Animal Probiotics Sweden AB
2022 – now
Board of Directors, Oncorena Research AB
2022 – now
Board of Directors, Oncorena AB
2022 – now
Board of Directors, nWise ägare AB
2022 – now
Deputy Board Member, Linc Ägande AB
2022 – now
Board of Directors, nWise AB
2022 – 2025
Board of Directors, Gesynta Pharma AB
2022 – 2023
Board of Directors, Plugit Charge AB
2022
Board of Directors, Melius Pharma AB
2020 – 2022
Deputy Board Member, Dunmedic AB
2020 – 2022
Deputy Board Member, Inpac Holding AB
2020 – 2021
Deputy Board Member, Cardiolex Medical AB
2014 – now
Stakeholder, Thomas Bergh

Personal details

Address

Uddens Gård

Companies & roles

Active roles

10 positions

Company	Role	Period	Ownership	Status
Animal Probiotics Sweden AB CVR 5566571179	BoardBoard of Directors	Since 2022	—	Active
Oncorena Research AB CVR 5568640808	BoardBoard of Directors	Since 2022	—	Active
Oncorena AB CVR 5569255192	BoardBoard of Directors	Since 2022	—	Active
nWise ägare AB CVR 5592768385	BoardBoard of Directors	Since 2022	—	Active
Linc Ägande AB CVR 5593066268	BoardDeputy Board Member	Since 2022	—	Active
Alder Therapeutics AB CVR 5593552762	BoardDeputy Board Member	Since 2026	—	Active
ACE Health AB CVR 5594433905	BoardBoard of Directors	Since 2024	—	Active
Välfärdspartner AB CVR 5594444191	BoardDeputy Board Member	Since 2023	—	Active
Thomas Bergh CVR 8205044830	OtherStakeholder	Since 2014	—	Active
nWise AB CVR 5567550354	BoardBoard of Directors	Since 2022	—	Active

Historical roles

6 positions

Company	Role	Period	Ownership	Status
Cardiolex Medical AB CVR 5565675153	BoardDeputy Board Member	2020 – 2021	—	Active
Dunmedic AB CVR 5565897534	BoardDeputy Board Member	2020 – 2022	—	Active
Inpac Holding AB CVR 5590471859	BoardDeputy Board Member	2020 – 2022	—	Active
Gesynta Pharma AB CVR 5591036628	BoardBoard of Directors	2022 – 2025	—	Active
Plugit Charge AB CVR 5593030843	BoardBoard of Directors	2022 – 2023	—	Active
Melius Pharma AB CVR 5593323669	BoardBoard of Directors	2022 – 2022	—	Active

Network

Company network

Active roles

Thomas Emanuel Bergh

Animal Probiotics Sweden AB

Alder Therapeutics AB

Past companies

Cardiolex Medical AB Dunmedic AB Inpac Holding AB Gesynta Pharma AB Plugit Charge AB Melius Pharma AB

Co-directors & shared companies

Person	Role	Shared companies	Profile
BI Björn Ingemar Odlander	Board of Directors	2companies	View profile
LC Lars Christer Fredrik Fåhraeus	Board of Directors	2companies	View profile
BS Börje Soini Haraldsson	Chief Executive Officer	2companies	View profile
SE Sofia Elin Elisabeth Heigis	Board of Directors	2companies	View profile
BM Bo Magnus Lagerberg	Chief Auditor	2companies	View profile

Is this you? About the data on this page

This profile is compiled automatically from Bolagsverket / SCB, the official business register in Sweden. Riskpilot is operated by Risika A/S, which is the data controller for this page. We don't add private information — only the roles and details the register itself publishes.

Because this is public register data, it can't be erased — corrections to the underlying record are made with the register, and we pick them up once they're published. You do have the right to object to how your details are shown here, and we can de-index this profile so it no longer appears in search engines such as Google.

To make a request, email privacy@risika.com with a link to this page. We respond within 30 days. Read more in our privacy policy.